Cordis (medical)

Cordis is a renowned medical device company that specializes in the development and manufacture of interventional vascular technology. The company's primary focus is on products for the cardiology, radiology, and endovascular surgery fields. Cordis was established in 1959 in Miami, Florida, and is currently a part of Cardinal Health, a global healthcare services and products company.

History[edit | edit source]

Cordis was founded by Don Miller and William P. Murphy Jr., a Nobel laureate in medicine. The company was initially established to develop and manufacture medical devices for interventional procedures in cardiology and radiology. In 1996, Cordis was acquired by Johnson & Johnson, a multinational corporation involved in the medical devices, pharmaceutical, and consumer packaged goods industries. In 2015, Cordis was sold to Cardinal Health.

Products[edit | edit source]

Cordis is known for its innovative products in the field of interventional cardiology, including stents, catheters, and guide wires. The company's most notable product is the Cypher Stent, the first drug-eluting stent approved by the Food and Drug Administration (FDA) in the United States.

Stents[edit | edit source]

Cordis produces a variety of stents for different medical applications. The Cypher Stent, for instance, is a coronary stent designed to prevent restenosis, a condition where the artery narrows again after treatment.

Catheters[edit | edit source]

Cordis manufactures a range of catheters for various interventional procedures. These include diagnostic catheters, guiding catheters, and percutaneous transluminal coronary angioplasty (PTCA) catheters.

Guide Wires[edit | edit source]

Guide wires from Cordis are used in a variety of interventional procedures. They are designed to navigate vessels to reach a lesion or vessel segment within the body.